PRTN3 and peripheral neuropathy: Compared with patients with positive MPO-ANCA and negative ANCA, patients with PR3+ ANCA less frequently developed active asthma and peripheral neuropathy and more frequently had cutaneous manifestations and pulmonary nodules and lower eosinophil count (17).